BVI SDK

The Body Volume Index SDK allows you to integrate the technology into your own existing tech platform, providing new body composition data and insights on your customers and clients.

BVI Risk SDK - Screenshot@3x.png

THE BENEFITS

GENERATE REVENUE

from in-app purchase opportunities

INCREASE ENGAGEMENT

with weight loss

programmes

USER RETENTION

increases when used with wellness programmes

DATA COLLECTION 

either identifiable, aggregated or anonymised results

HOW IT WORKS

Results are scientifically interpreted by calculating body composition, providing an overall indication of your health and risk. The BVI SDK is an easy option should you wish to improve your health risk testing with BVI's measurement process. Our SDK is easy to integrate and can sit within your app, website or ERM system to help improve your health risk assessment process. BMI or weight do not provide the best measure of physical health. BVI uses your smartphone camera to analyse body fat and composition, a better indicator of health than weight or BMI alone. 

X-Ray Results

CASE STUDY

“We currently only give health benefits to middle management, but the insights provided by BVI across the wider workforce have really helped us to improve staff health and reduce the number of sick days. BVI technology really benefits shop floor workers as there is currently nothing in place for them, where obesity-related sick days can be a real problem and the key staff members tend to be of a demographic (age, health and fitness) that seem to suit BVI.”  

- a FTSE 250 retailer

Interested in integrating our digital solution?

Get in touch below, please provide as much detail as possible and a member of our team will be in touch

FOLLOW US

Stay connected with the latest from BVI over on our social platforms:

  • LinkedIn
  • Facebook
  • Twitter
  • YouTube
  • Instagram

CONTACT

Body Volume Index

Malvern Hills Science Park,

Geraldine Rd, Malvern,

United Kingdom

info@select-research.com

NAVIGATE

BVI® is protected by Trademarks; 

EU 005496781 and US 3,571,066, granted patents; US 8,374,671 B2 and EP 1993443 and pending patents stemming from WO2018197896A1, including AU 2018258129, EP 2018722172, CN 201880042366.1, and SG 11202006038S.

©2020 by Select Research Ltd